ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentAllschwilGlioCART GmbH
GlioCART GmbH Logo
Verified· 2 sourcesTrust Score
Summary

About the company

GlioCART GmbH develops a dual-action CAR-T therapy for glioblastoma. The company focuses on directly attacking tumor cells while also reprogramming the immunosuppressive tumor microenvironment.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentOther Specialist Clinics
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
No score yet

GlioCART GmbH

Pharmaceutical Industry
✓ Offered2
CAR-T Therapy for Glioblastoma
Dual-action CAR-T therapy for glioblastoma with direct tumour cell killing, EGFRvIII targeting, CD47 blockade and reprogramming of tumour-associated macrophages.
Pipeline of Next-Generation CAR-T Therapies
Pipeline of next-generation CAR-T therapies with a focused glioblastoma program and scalable platform approach for additional myeloid-driven solid tumours.
Trust & reputation

ranQ Trust Score of GlioCART GmbH

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Website authority, Media authority

Data basis 50% · As of October 2026

GlioCART GmbH has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
GlioCART GmbH scores 50.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.25.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
GlioCART GmbH scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
GlioCART GmbH has no value in the Visibility area of the ranQ Trust Score because no data is available. The area carries 8% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Website authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 50%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Website authority, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once GlioCART GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

GlioCART GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank GlioCART GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of GlioCART GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Kreuzstrasse 4
4123 Allschwil

At a glance

Legal form
Limited Liability Company
UID
CHE-258.113.208
Founded
2025 · 1 year
Last commercial register change
November 17, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
88.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    IA
    InCephalo AG
    Allschwil
    IT
    Immuna Therapeutics AG
    Allschwil
    AP
    Actelion Pharmaceuticals Ltd
    Allschwil
    OA
    OncoGenomX AG
    Allschwil
    BP
    Bright Peak Therapeutics AG
    Allschwil
    IA
    INNOSIAMO AG
    Allschwil
    PP
    Perseo pharma AG
    Muttenz
    SF
    Stiftung Forschung Klinik Arlesheim
    Arlesheim